Participants must be receiving acetylcholinesterase inhibitors on a stable dose for at least 4 months prior to randomization

Exclusion Criteria:

Current evidence or history of neurological, psychiatric and any other illness that could contribute to non-Alzheimer's dementia.

Known history of familial AD or any evidence for early onset AD known or possibly associated with genetic mutations.

Evidence or history of diabetes mellitus Type 1 or Type 2.

History or symptoms of autoimmune disorders.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00566397